MoneyWorks4Me

Ambalal Sarabhai Ent reports Profit after tax of Rs 5.61 Mln, in the September 2023 quarter

07 Nov 2023 Evaluate
The sales slipped to Rs. 7.96 millions for the September 2023 quarter as against Rs. 9.28 millions during the year-ago period.Profit saw a slight increase of 7.47%to Rs. 5.61  millions from Rs. 5.22 millions.A decline of 6.34 millions was observed in the OP in the quarter ended September 2023 from 6.79 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202309 202209 % Var 202309 202209 % Var 202303 202203 % Var
Sales 7.96 9.28 -14.22 25.00 21.20 17.92 37.07 1.27 2818.90
Other Income 19.65 19.91 -1.31 31.46 44.00 -28.50 105.34 395.35 -73.36
PBIDT 6.34 6.79 -6.63 -13.35 16.57 -180.57 53.76 339.68 -84.17
Interest 0.44 0.08 450.00 0.69 0.41 68.29 1.07 2.47 -56.68
PBDT 5.90 6.71 -12.07 -14.04 15.73 -189.26 44.81 36.44 22.97
Depreciation 0.29 0.43 -32.56 0.58 0.85 -31.76 1.45 1.92 -24.48
PBT 5.61 6.28 -10.67 -14.62 14.88 -198.25 43.36 34.52 25.61
TAX 0.00 1.06 -100.00 0.00 1.11 -100.00 2.26 4.96 -54.44
Deferred Tax 0.00 1.06 -100.00 0.00 1.11 -100.00 2.26 7.46 -69.71
PAT 5.61 5.22 7.47 -14.62 13.77 -206.17 41.10 29.56 39.04
Equity 766.33 766.33 0.00 766.33 766.33 0.00 766.33 766.33 0.00
PBIDTM(%) 79.65 73.17 8.86 -53.40 78.16 -168.32 145.02 26746.46 -99.46
Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..